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C57BL/6 (B6) and B6 background STAT6
 
 
 
/
 
 
 
 mice pretreated with IL-18 plus IL-2 showed 
prominent intestinal mastocytosis and rapidly expelled implanted adult worms of the 
gastrointestinal nematode 
 
Strongyloides venezuelensis
 
. In contrast, identically pretreated 
mast cell–deficient W/W
 
v
 
 mice failed to do so. Thus, activated mucosal mast cells (MMC) 
are crucial for parasite expulsion. B6 mice infected with 
 
S. venezuelensis 
 
third-stage larvae 
(L3) completed parasite expulsion by day 12 after infection, whereas IL-18
 
 
 
/
 
 
 
 or IL-18R
 
 
 
 
 
/
 
 
 
 
B6 mice exhibited marked impairment in parasite expulsion, suggesting a substantial 
contribution of IL-18–dependent MMC activation to parasite expulsion. Compared with 
IL-18
 
 
 
/
 
 
 
 or IL-18R
 
 
 
 
 
/
 
 
 
 mice, 
 
S. venezuelensis
 
 L3–infected STAT6
 
 
 
/
 
 
 
 mice have poorly 
activated MMC and sustained infection; although their IL-18 production is normal. 
Neutralization of IL-18 and IL-2 further reduces expulsion in infected STAT6
 
 
 
/
 
 
 
 mice. These 
results suggest that collaboration between IL-18–dependent and Th2 cell–dependent 
mastocytosis is important for prompt parasite expulsion.
 
Microbes can be classified into intracellular
and extracellular types. In general, intracellular
microbes are expelled by cell-mediated immu-
nity (Th1 responses), whereas extracellular
microbe eradication often is mediated by the
function of humoral immunity (Th2 responses;
references 1–6). Upon infection with intracellu-
lar  microbes, macrophages or DCs produce
various types of proinflammatory cytokines in re-
sponse to Toll-like-receptor/MyD88-mediated
signaling (7, 8). Among the proinflammatory
cytokines produced, IL-12 and IL-18 are most
important up-stream cytokines of IFN-
 
 
 
 and
synergistically induce T cells, B cells, NK cells,
macrophages, and DCs to produce IFN-
 
 
 
 (9–
16). Resultant IFN-
 
 
 
 then activates macrophages
to produce nitric oxide, leading to eradication
of intracellular pathogens (3–5). Indeed, IL-12–
and/or IL-18–deficient mice show markedly
reduced host resistance against 
 
Cryptococcus neofor-
mans
 
 or 
 
Leishmania major
 
 (17–19). Thus, both
IL-12 and IL-18 are important for host defense
against intracellular microbes. However, our
recent studies clarified that IL-18 without help
from IL-12 induces Th2 cytokines in T cells,
basophils, and mast cells (4, 20–23). Most sur-
prisingly, administration of IL-18 or IL-18 plus
IL-2 into naive mice induces IgE in a CD4
 
 
 
 T
cell–, IL-4–, and STAT6–dependent manner
(20–22). Moreover, transgenic mice overex-
pressing IL-18 in their keratinocytes spontane-
ously produce IgE (21, 24) and develop atopic
dermatitis (25). Thus, IL-18 regulates both
Th1 and Th2 responses depending on its cy-
tokine milieu (4).
It is well known that expulsion of some
types of helminthes depends on the action of
activated mast cells (2). Here we demonstrate
that treatment of mice with daily injection of
IL-2 plus IL-18 induces significant increases in
the number of intestinal mucosal mast cells
(MMCs) and in their release of mouse mast cell
protease-1 (mMCP-1), which are hallmarks of
infection with gastrointestinal nematode (2,
26–29). Furthermore, this pretreatment pre-
pares them to expel implanted adult worms of
 
Strongyloides venezuelensis
 
 rapidly. In contrast,
identically pretreated W/W
 
v
 
 mice that lack
mast cells (30) failed to expel implanted
worms. These results suggest that IL-18– and
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IL-2–dependent MMC activation is indispensable for rapid par-
asite expulsion. WT mice inoculated with 
 
S. venezuelensis
 
 third-
stage larvae (L3) showed significant increases both in serum IL-
18 and mMCP-1 levels and completed worm expulsion by 12 d.
In contrast, IL-18–deficient (IL-18
 
 
 
/
 
 
 
) or IL-18R
 
 
 
 
 
/
 
 
 
 mice
required longer period to complete worm expulsion. STAT6
 
 
 
/
 
 
 
mice infected with 
 
S. venezuelensis
 
 L3 showed more severe im-
pairment in parasite expulsion, and neutralization of IL-18 and
IL-2 further reduced their capacity to expel the parasite. Here,
we demonstrate that both IL-18–dependent and Th2 cytokine–
dependent MMC activation pathways are critically involved in
induction of rapid parasite expulsion.
 
RESULTS
Intestinal MMC accumulation in WT mice injected 
with IL-18 plus IL-2
 
We first tested whether daily i.p. injection of IL-2 and/or
IL-18 induces accumulation of MMC in intestines of the
mice. Stained jejunal sections revealed that administration of
IL-18 (2 
 
 
 
g/d) and IL-2 (2,000 U/d) induced MMC, al-
though treatment with each component alone did not in-
duce or induced it weakly (Fig. 1 A). Titration study indi-
cated that IL-18 stimulated a dose-dependent increase in
MMC when combined with IL-2 (2,000 U/d) (Fig. 1 B).
We injected 2,000 U/d of IL-2. Much higher doses of IL-2
(e.g., 10
 
4
 
 U/d) failed to enhance this response (unpublished
data). We compared the degree of accumulation of MMC in
the mice treated with IL-2 and IL-18 with that in mice in-
oculated with 
 
S. venezuelensis
 
 L3 2 wk earlier and found that
infection with 
 
S. venezuelensis
 
 L3 showed more potent
MMC-inducing activity (Fig. 1 A, d and f, and B). The ef-
fect of IL-2 and IL-18 was prominent in intestines, and no
mast cell accumulation was observed in other organs, such as
lungs, spleens, livers, and kidneys.
Because IL-3, IL-4, and IL-9 are well-known potent
mast cell growth factors (30–32), we simultaneously mea-
sured serum levels of these cytokines at various time points
after treatment of mice with IL-2 plus IL-18. As shown in
Fig. 1 C, administration of IL-18 (2 
 
 
 
g/d) and IL-2 (2,000
U/d) induced increases in serum levels of IL-3, IL-4, IL-9,
and IL-13. In general, these cytokines are below the detec-
tion level in normal mice. However, serum levels of IL-3,
IL-4, and IL-9 increased in mice injected with IL-2 and
IL-18 and peaked at d 7; IL-13 was persistently elevated
even beyond d 7. IL-18 treatment alone induced IL-4 very
modestly (30 pg/ml). Neither IL-10 nor IFN-
 
 
 
 was de-
tected in the sera of mice injected with IL-18 plus IL-2
(unpublished data).
Figure 1. IL-18– plus IL-2–induced intestinal MMC accumulation in 
vivo. (A) C57BL/6 mice (six to eight mice per group) were injected daily i.p. 
with PBS alone or with IL-18 (0.5–2  g/d) and/or IL-2 (2,000 U/d) for 13 d or 
were inoculated with 5,000 S. venezuelensis L3. 14 d after cytokine treatments 
or inoculation with S. venezuelensis L3, intestine tissue samples (8–10 cm 
from the pyloric ring) were removed and fixed in Carnoy’s fluid and stained 
with Alcian blue, pH 0.3, and Safranin-O. Original magnification, 200. (B) The 
number of mast cells in the epithelium and lamina propria mucosa was 
counted in 10 VCU. Results are geometric means   SD. ND; not detected. 
(C) C57BL/6 mice (six to eight mice per group) were injected daily with IL-18 
(2  g/d) plus IL-2 (2,000 U/d) for 13 d. They were bled 0, 4, 7, 10, and 14 d 
later, and serum IL-3, IL-4, IL-9, and IL-13 levels were measured by ELISA. 
Results are geometric means   SEM. *,  3 pg/ml; **,  10 pg/ml; 
†,  20 pg/ml. Results are representative of three independent experiments. 
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mMCP-1 production by activated intestinal MMC in mice 
injected with IL-18 plus IL-2
 
It is well known that the serum level of mMCP-1 correlates
very well with the degree of intestinal MMC activation that is
associated with mucosal mast cell degranulation (26–29).
Thus, we examined whether accumulated MMCs were acti-
vated to produce mMCP-1 in mice treated with IL-2 plus IL-
18. As shown in Fig. 2 A, the serum level of mMCP-1 was
below the detection level under normal conditions. However,
when mice received a daily injection of IL-18 (2 
 
 
 
g/d), the
mMCP-1 level in their sera increased (day 7, 19.5 ng/ml; day
10, 39.58 ng/ml; day 14, 55.6 ng/ml). Coinjection of IL-2
markedly increased these serum mMCP-1 levels. IL-18 in-
duced a dose-dependent increase in mMCP-1 levels in mice
treated with IL-2 (2,000 U/d; Fig. 2 A). We found that serum
level of mMCP-1 in the mice injected with IL-18 (2 
 
 
 
g/d)
and IL-2 (2,000 U/d) was almost comparable with that in the
mice inoculated with 
 
S. venezuelensis
 
 L3 (Fig. 2 A).
In addition to the effect of IL-18 and IL-2 on serum
mMCP-1 level, stained jejunal sections indicated that this
Figure 2. IL-18– plus IL-2–induced mMCP-1 production in vivo. 
(A) C57BL/6 mice (six to eight mice per group) were injected i.p. daily with 
IL-18 (2  g/d) or with various doses of IL-18 (0.5–2  g/d) and IL-2 (2,000 U/d) 
for 13 d or were inoculated with 5,000 S. venezuelensis L3. They were bled 
0, 4, 7, 10, and 14 d later, and mMCP-1 in sera was measured by ELISA. 
Results are geometric means   SEM. ND; not detected. (B) C57BL/6 mice 
(six to eight mice per group) were injected daily with PBS or with IL-18 
(2  g/d) and IL-2 (2,000 U/d) for 13 d or were inoculated with 5,000 
S. venezuelensis L3. 14 d after treatments, upper intestines were removed 
and fixed with 4% paraformaldehyde. Immunohistochemical staining for 
mMCP-1 was performed as described in Materials and methods. Results 
are representative of three independent experiments.
Figure 3. IL-18– plus IL-2–induced CD4  T cell–dependent but 
STAT6-independent intestinal mastocytosis. C57BL/6 WT and C57BL/6-
background RAG-2 /  (RAG / ) or STAT6 /  mice (six mice per group) 
were injected i.p. daily with IL-18 (2  g/d) and/or IL-2 (2,000 U/d) for 13 d. 
To deplete CD4  T cells, C57BL/6 mice received anti-CD4 (GK1.5; 0.5 mg/d) 
or control antibody (rat IgG2b; 0.5 mg/d) 7 and 4 d before IL-2 and IL-18 
treatment and 0, 3, and 7 d after treatment. (A) 14 d after IL-2 and IL-18 
treatment, tissue samples (8–10 cm) from the pyloric ring were removed 
and fixed in Carnoy’s fluid and stained with Alcian blue, pH 0.3, and 
Safranin-O. Original magnification, 200. (B) The number of mast cells in 
the epithelium and lamina propria mucosa was counted in 10 VCU. Results 
are geometric means   SD. Mice were bled 0, 7, 10, and 14 d later, and 
serum mMCP-1 was measured by ELISA. Results are geometric means   
SEM. *, P   0.01; †, P   0.001 by Student’s t test as compared with mice 
treated with control antibody. Results are representative of three indepen-
dent experiments. (C) STAT6 /  mice (eight mice per group) were injected 
i.p.daily with IL-18 (2  g/d) and/or IL-2 (2,000 U/d) for 13 d. Four mice 
from each group received a mixture of anti-IL-4 antibody (10 mg/d) and 
anti-IL-4R antibody (10 mg/d) 1 d before IL-2 and IL-18 treatment and 
4 and 8 d after treatment. They were bled 0, 4, 7, 10, and 14 d later, 
and serum mMCP-1 was measured by ELISA. Results are geometric
means   SEM. Results are representative of two independent experi-
ments. (D and E) C57BL/6 normal mice (five mice per group) were injected 
daily for 13 d (D) with PBS alone or with IL-3 (0.013  g/d) and/or IL-9 (0.5 
 g/d) or (E) with PBS alone or with IL-3 (0.1  g/d) and/or IL-9 (0.5  g/d). 
They were bled 0, 4, 7, 10, and 14 d later, and serum mMCP-1 levels were 
measured by ELISA. Results are geometric means   SEM. ND; not
detected. Results are representative of three independent experiments. 
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treatment markedly increased the number of mMCP-1–pos-
itive cells (Fig. 2 B). Their distribution is very similar to that
of MMC (Fig. 1 A and Fig. 2 B). Furthermore, like MMC,
mMCP-1–positive cells were prominent in intestines and
were not observed in the lungs, spleens, livers, and kidneys
of the mice injected with IL-18 and IL-2 (unpublished data).
Taken together, these results clearly indicated that treatment
with IL-18 and IL-2 induces accumulation, maturation, and
activation of intestinal MMC, namely intestinal mastocytosis.
 
CD4
 
 
 
 T cell–dependent but STAT6-independent 
mastocytosis in mice injected with IL-18 plus IL-2
 
To determine whether this intestinal mastocytosis induced by
IL-18 plus IL-2 is dependent on the function of CD4
 
 
 
 T cells,
we injected IL-2 and IL-18 into C57BL/6 WT mice depleted
of CD4
 
 
 
 T cells by pretreatment with anti-CD4 antibody or
into C57BL/6 RAG-2–deficient (RAG-2
 
 
 
/
 
 
 
) mice lacking
both T cells and B cells. Anti-CD4 treatment significantly im-
paired IL-2– and IL-18–induced intestinal mastocytosis (Fig.
3, A and B) and mMCP-1 production (P 
 
 
 
 0.01; Fig. 3 B).
Furthermore, RAG-2
 
 
 
/
 
 
 
 mice injected with IL-18 plus IL-2
showed very poor accumulation of MMC and very low se-
rum levels of mMCP-1 (Fig. 3, A and B). These results clearly
indicated that IL-18– plus IL-2–induced accumulation of in-
testinal MMC is dependent on the function of CD4
 
 
 
 T cells.
Injection of IL-2 and IL-18 induced increases in the se-
rum levels of IL-3, IL-4, IL-9, and IL-13 (Fig. 1 C). We pre-
viously reported that IL-2 and IL-18 stimulate CD4
 
 
 
 T cells
from C57BL/6 or C57BL/6 background STAT6
 
 
 
/
 
 
 
 mice to
produce IL-3, IL-4, IL-9, and IL-13 (21, 22). Because IL-4
was shown to induce intestinal mastocytosis in a STAT6-
independent manner (33, 34), we injected IL-2 and IL-18
into STAT6
 
 
 
/
 
 
 
 mice and examined the accumulation of MMC.
STAT6
 
 
 
/
 
 
 
 mice displayed intestinal mastocytosis and high
serum levels of mMCP-1 (Fig. 3, A and B) when injected
with IL-2 and IL-18, suggesting STAT6-independent IL-4
induction of mastocytosis. However, blockage of IL-4 only
partly inhibited the IL-2–plus IL-18–induced mMCP-1 re-
sponse (Fig. 3 C). Thus, the effect of IL-4 was modest, and
induction of mMCP-1 requires the participation of other
factors. Because IL-3 and IL-9 can induce MMC in vivo
(30–32), we daily injected IL-3 (0.013 
 
 
 
g/d) and IL-9 (0.5
 
 
 
g/d) into C57BL/6 WT mice. This treatment only par-
tially replaced the effect of IL-2 and IL-18 (Fig. 3 D). How-
ever, a higher dose of IL-3 (0.1 
 
 
 
g/d) even without IL-9
strongly increased the serum level of mMCP-1, and addi-
tional IL-9 stimulation enhanced this effect modestly (Fig. 3
E). Thus, IL-2 plus IL-18 treatment seems to induce
mMCP-1 by virtue of IL-3 and IL-9 from CD4
 
 
 
 T cells,
and IL-3 seems to be most critical for mMCP-1 induction.
Rapid expulsion of implanted adult S. venezuelensis by mice 
treated with IL-18 plus IL-2
Because the degree of parasite expulsion is closely associated
with the degree of intestinal mastocytosis in the mice in-
fected with S. venezuelensis (35, 36), we examined the pro-
tective role of IL-2– and IL-18–induced MMC against S.
venezuelensis infection. Thus, we implanted adult worms in
the duodenum of mice pretreated with IL-2 and/or IL-18
for 13 d. We recovered invading parasites at 16 h after im-
plantation (Fig. 4 A; reference 36). A considerable number
of the parasites were shown to invade intestines of the mice
that received PBS, IL-2, or IL-18 alone. Furthermore, these
mice remained heavily infected up to 7 d after treatment
(unpublished data). In contrast, mice pretreated with IL-18
plus IL-2 almost completely rejected them (P   0.0001; Fig.
4 A), revealing this expulsion was a rapid response. In these
experiments, we injected 2 g/d of IL-18 together with IL-2
into naive mice. However, we found that a much lower
dose of IL-18 (0.5  g/d) equally prepared mice to expel im-
planted parasites rapidly (unpublished data). It is important to
start injection of a mixture of IL-2 and IL-18 before implan-
Figure 4. IL-18– plus IL-2–induced MMC-dependent expulsion of 
adult S. venezuelensis. Adult S. venezuelensis. (1,500 worms/mouse) were 
implanted in the duodenum of recipient (A) C57BL/6 WT mice and (B) 
C57BL/6-background STAT6 /  , WBB6F1 / , and WBB6F1-W/Wv mice that 
had been injected i.p. daily with PBS alone or with IL-18 (2  g/d) and/or IL-2 
(2,000 U/d) for 13 d. 16 h after implantation, the mouse intestines ware 
removed, cut open longitudinally, and washed lightly to remove fecal matter 
and worms that were still in the lumen. Then the intestines were incubated 
in PBS at 37 C for 3 h. The number of worms that emerged from the intes-
tines was counted. Results are geometric means   SD of eight animals 
per group and are representative of more than three independent experiments. 
†, P   0.0001 by Student’s t test as compared with PBS control groups.JEM VOL. 202, September 5, 2005 611
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tation (unpublished data), because appreciable induction of
MMC required  10 d (Fig. 2 A). These results clearly indi-
cated that only mice pretreated with IL-2 plus IL-18 gained
the capacity to expel implanted adult parasites rapidly. As ex-
pected from the results shown in Fig. 3, STAT6 /  mice
pretreated with IL-2 and IL-18 also gained the capacity to
reject implanted parasites rapidly (Fig. 4 B).
Next, we examined whether mastocytosis induced by
IL-2 plus IL-18 is critically involved in the expulsion of im-
planted parasites. Thus, we treated mast cell–deficient W/Wv
mice with IL-2 and IL-18 and examined their capacity to
expel parasites. We found these mice failed to respond to this
treatment by intestinal MMC accumulation and mMCP-1
production (unpublished data). Furthermore, they could not
reject implanted parasites (Fig. 4 B). These results clearly in-
dicated that rapid expulsion of implanted adult worms is me-
diated by the function of activated MMC.
Partial contribution of activated MMC to expulsion 
of S. venezuelensis L3
In the preceding section, we demonstrated that MMC ac-
tivation is indispensable for rapid expulsion of implanted
adult worms. Next, it was important to determine
whether MMCs are also critically involved in host defense
against S. venezuelensis L3 infection. Thus, we inoculated
control mice and mast cell–deficient W/Wv mice (37)
with 5,000 S. venezuelensis L3. We daily counted fecal egg
number (eggs/g of feces). We simultaneously tested
whether this S. venezuelensis L3 infection induced IL-18
production and found that both types of mice clearly pro-
duced IL-18 (Fig. 5 A). However, only control mice, but
not W/Wv mice, produced mMCP-1 (Fig. 5 B). Thus,
MMCs are the only cell source of mMCP-1 during S. ven-
ezuelensis L3 infection. Inoculated control mice completed
parasite expulsion by day 13, whereas production of the
parasites’ eggs was significantly prolonged in W/Wv mice
(Fig. 5 C). These results suggest that activated MMC
markedly shortened the time required for parasite expul-
sion. However, we should be cautious in concluding that
delayed worm expulsion by W/Wv mice reflects only a
mast cell defect. These mice have defects in peristalsis (38)
and intestinal T cell populations (39), as well as a mast cell
defect. Despite these defects, W/Wv mice eventually ex-
pelled parasites by day 20 (Fig. 5 C), suggesting contribu-
tion of MMC-independent parasite expulsion mechanism.
Indeed, W/Wv mice infected by S. venezuelensis showed a
markedly augmented IgE response (Fig. 5 D), and deple-
tion of CD4  T cells abrogated their capacity to expel par-
asite and to produce IgE (Fig. 5, E and F). Thus, Th2 cells
also play a protective role for parasite expulsion.
Impaired expulsion of S. venezuelensis L3 without help 
from endogenous IL-18
To address the role of endogenous IL-18 in the host defense
against S. venezuelensis L3 infection, the capacity of IL-18 / 
mice and IL-18R  /  mice to expel S. venezuelensis was
examined. C57BL/6 WT, C57BL/6 background IL-18 / 
and IL-18R  /  mice were inoculated with 5,000 S. vene-
zuelensis L3. As shown in Fig. 6 A, IL-18 /  and IL-18R  / 
mice, compared with infected WT mice, exhibited signifi-
cantly prolonged production of the parasites’ eggs, but they
could expel worms by day 16. We found these deficient
mice also exhibited significantly reduced levels of mMCP-1
at day 4, 7, and 10 after infection (Fig. 6 B), suggesting the
importance of endogenous IL-18 for early induction of
mMCP-1. However, these deficient mice and WT mice
Figure 5. Role of MMC against S. venezuelensis L3. (A and B) Serum 
levels of (A) IL-18 and (B) mMCP-1 from WBB6F1 /  and WBB6F1-W/Wv 
mice inoculated with 5,000 S. venezuelensis L3. Results are geometric 
means   SEM of five animals per group and are representative of three 
independent experiments. *, P   0.01; †, P   0.001 by Student’s t test as 
compared with day 0. (C ) Kinetics of the number of eggs per g feces and 
(D) serum levels of IgE from WBB6F1 /  and WBB6F1-W/Wv mice inocu-
lated with 5,000 S. venezuelensis L3. Results are geometric means   SEM 
of five animals per group. *, P   0.01; †, P   0.005 versus corresponding 
value for WBB6F1 /  mice. (E) Kinetics of the number of eggs per g feces 
and (F) serum levels of IgE from WBB6F1 /  mice, WBB6F1-W/Wv mice, 
and CD4  T cell–depleted WBB6F1-W/Wv mice inoculated with 5,000 
S. venezuelensis L3. To deplete CD4  T cells, WBB6F1-W/Wv mice were 
injected with anti-CD4 antibody (0.5 mg/d) on days 7 and 4 before infection 
and two times per wk after infection. Results are geometric means   SEM 
of five animals per group. *, P   0.01; †, P   0.005 versus corresponding 
value for WBB6F1-W/Wv mice without anti-CD4 antibody treatment.IL-INDUCED MMC IN NEMATODE EXPULSION | Sasaki et al. 612
showed comparable levels of mMCP-1 in their sera at day
14 (Fig. 6 B), suggesting that this late mMCP-1 induction is
independent of endogenous IL-18 and possibly is dependent
on Th2 cells generated thereafter.
Remarkable prolongation of S. venezuelensis L3 expulsion 
without help from Th2 cytokines and endogenous IL-18
To determine the relative contribution of Th2 cells and en-
dogenous IL-18 to parasite expulsion, we compared the ca-
pacity of STAT6 /  mice receiving control antibody or
anti-IL-18 and/or anti-IL-2 antibodies to expel S. venezue-
lensis. STAT 6 /  mice inoculated with S. venezuelensis L3
increased their serum IL-18 levels during infection (Fig. 7
A). Inoculated STAT 6 /  mice required 23 d to expel par-
asites (Fig. 7 B), perhaps because of their inability to pro-
duce mMCP-1 promptly (Fig. 7 C). However, they started
to produce mMCP-1 at day 14 and sustained substantial
levels of mMCP-1 up to day 21 after infection (Fig. 7 C).
Anti-IL-18 antibody treatment only modestly prolonged
the time required for parasite expulsion (Fig. 7 B) and
reduced serum mMCP-1 level (Fig. 7 C). However,
STAT6 /  mice injected with anti-IL-2/anti-IL-18 exhib-
ited more profound defects in their ability to expel S. vene-
zuelensis and to produce mMCP-1 than did STAT6 / 
mice (Fig. 7, B and C), although neutralization of IL-2
alone did not affect parasite expulsion and serum levels of
mMCP-1 (Fig. 7, B and C). These results taken together
indicated involvement of two types of intestinal MMC acti-
vation, IL-18– plus IL-2–dependent and Th2 cell–depen-
dent activation, for S. venezuelensis expulsion.
DISCUSSION
Here we show that pretreatment with IL-18 and IL-2 pre-
pares mice to expel implanted adult worms promptly by in-
duction of intestinal mastocytosis. We also show the relevant
role of endogenous IL-18 for expulsion of S. venezuelensis L3
Figure 6. Role of endogenous IL-18 against S. venezuelensis L3. 
Kinetics of (A) the number of eggs per g feces and (B) serum levels of 
mMCP-1 from WT, IL-18 / , and IL-18R  /  mice inoculated with 5,000 
S. venezuelensis L3. Results are geometric means   SEM of eight animals 
per group and are representative of three independent experiments. 
*, P   0.01; †, P   0.005 versus corresponding value for WT mice.
Figure 7. Role of Th2 cytokines and endogenous IL-18 against 
S. venezuelensis L3. (A) Serum levels of IL-18 from WT and STAT6 /  
mice inoculated with 5,000 S. venezuelensis L3. Results are geometric 
means   SEM of five animals per group and are representative of three 
independent experiments. Ab, antibody; *, P   0.01; †, P   0.001 by 
Student’s t test as compared with day 0. (B) Kinetics of the number of 
eggs per g feces and (C) serum levels of mMCP-1 from WT and STAT6 /  
mice inoculated with 5,000 S. venezuelensis L3. STAT6 /  mice inoculated 
with S. venezuelensis L3 were injected intravenously with anti-IL-18 
(800  g/d) and/or anti-IL-2 (100  g/d) or control antibody (rabbit IgG 
and rat IgG2b) two times per wk for 2 wk after infection. Results are 
geometric means   SEM of five animals per group and are representative 
of three independent experiments. Ab, antibody; †, P   0.005 versus 
corresponding value for STAT6 /  mice injected with control antibody.JEM VOL. 202, September 5, 2005 613
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by using IL-18 /  or IL-18R  /  mice. Finally, we show
the collaborative action of IL-18–dependently activated
MMC and Th2 cell–dependently activated MMC for rapid
parasite expulsion.
The role of intestinal MMC in worm expulsion has been
studied extensively in various experimental host–parasite sys-
tems. In the case of infection with S. venezuelensis L3, host
mice complete parasite expulsion within 2 wk, and the ex-
pulsion is tightly associated with level of intestinal mastocyto-
sis (35, 36). In contrast, mast cell–deficient W/Wv mice in-
fected with S. venezuelensis L3 show a significant delay in
parasite expulsion (35). Furthermore, parasite expulsion is
more severely impaired in W/Wv mice that are deficient for
IL-3 gene expression. In these mice, MMC responses are al-
most completely absent, and S. venezuelensis continue to par-
asitize in the intestine for  50 d (35). In this study, we have
demonstrated that depletion of CD4  T cells in W/Wv mice
further abrogated their capacity of to expel the parasite (Fig. 5
E). Thus, Th2 cells display their protective role against para-
site even in the absence of activated MMC.
It is well established that mMCP-1, selectively expressed
by intestinal MMC, participates in the effecter-phase re-
sponse to expulsion of intestinal nematodes (2, 26–29).
Miller et al.. reported that mMCP-1 is not detectable in the
culture of BM-derived mast cells stimulated with IL-3 and
IL-9 (40). However, mast cells begin to produce mMCP-1
when additionally stimulated with SCF and TGF- . Here,
we have demonstrated that daily injection of a mixture of
IL-18 and IL-2 induces intestinal mastocytosis (Fig. 1 A) and
an increase in the serum level of mMCP-1 (Fig. 2 A). This
serum level of mMCP-1 is somewhat lower than that seen in
WT mice infected with S. venezuelensis L3 for 14 d (Fig. 2
A). We have also demonstrated that mast cell–deficient W/Wv
mice failed to produce mMCP-1 in response to the treat-
ment with IL-18 and IL-2 or to the inoculation with S. ven-
ezuelensis L3 (Fig. 5 B). Based on these observations, we
could conclude that MMC is the only producer of mMCP-1
in these circumstances.
Treatment of normal mice with IL-18 and IL-2 induced
IL-3, IL-4, IL-9, and IL-13 (Fig. 1 C). Like WT mice treated
with Il-18 plus IL-2, STAT6 /  mice displayed intestinal
mastocytosis and increased serum levels of mMCP-1 after IL-
18 plus IL-2 treatment (Fig. 3, A and B). Finkelman et al.
have previously reported that IL-4 treatment significantly in-
creased the number of MMC in both WT and STAT6 / 
mice and that a much larger increase was observed in the
latter, indicating that signaling through STAT6 seems to sup-
press IL-4 induction of MMC (33, 34). However, the IL-18–
plus IL-2–induced mMCP-1 response in STAT6 /  mice was
inhibited only partly by blocking IL-4 (Fig. 3 C), suggesting
contributions of other cytokines to mMCP-1 induction. Be-
cause CD4  T cells stimulated by IL-18 plus IL-2 produce IL-3
and IL-9 as well as IL-4 and IL-13, we examined whether
daily treatment with IL-3 (0.013  g/d) and IL-9 (0.5  g/d)
for 2 wk could replace IL-18 and IL-2-treatment. We found
this treatment only partly replaced the effect of IL-2 plus IL-
18 treatment on serum mMCP-1 level. However, a much
higher dose of IL-3 (0.1  g/d), even without IL-9, replaced
the effect of IL-2 and IL-18 (Fig. 3 E). Thus, we considered
the possibility that a set of Th2 cytokines, including IL-3, IL-4,
and IL-9, have an orchestrated action on mMCP-1 induction,
and that neutralization of single factor could not effectively in-
hibit this orchestration.
In this report, we first showed that induction of intestinal
mastocytosis by treatment with IL-18 plus IL-2 is sufficient
to expel implanted adult worms. However, as we reported
in the subsequent section, host defense against S. venezuelen-
sis L3 infection is more complicated. We examined the con-
tribution of endogenous IL-18 to parasite expulsion by using
IL-18 /  or IL-18R  /  mice. WT mice infected with S.
venezuelensis L3 showed a significant increase in serum levels
of IL-18 (days 4–14) and mMCP-1 (days 7–21) and com-
pleted worm expulsion within 12 d (Fig. 6 A). In contrast,
IL-18 /  or IL-18R  /  mice infected with S. venezuelensis
L3 exhibited significantly reduced serum levels of mMCP-1
at days 4, 7, and 10 after infection, and worm expulsion was
significantly delayed as compared with WT mice (Fig. 6 A).
A reason for this delay might be that, like WT mice, both
IL-18 /  and IL-18R  /  mice inoculated with S. venezue-
lensis L3 generated a Th2 response (unpublished data; refer-
ence 22). Thus, we assumed the possible contribution of
Th2 cells to this late-phase worm expulsion.
IL-18 also is definitively involved in the host defense of
STAT6 /  mice. Because of their defective Th2 cell devel-
opment, they required a much longer period to expel para-
sites. Anti-IL-2 or anti-IL-18 treatment alone showed little
effect on parasite expulsion, whereas anti-IL-18 plus anti-IL-2
treatment markedly impaired the parasite expulsion and
significantly reduced mMCP-1 production (P   0.005; Fig.
7, B and C). Nevertheless, STAT6 /  mice treated with
anti-IL-2/anti-IL-18 still displayed mMCP-1 response after
parasite infection. These results suggest participation of other
factors in induction of mMCP-1. Recent reports have
clearly demonstrated that nematode infection induces Th2
cytokines from basophils in the lung, liver, and spleen (41,
42), suggesting their contribution to mMCP-1 induction in
STAT6 /  mice.
As noted previously, neutralization of IL-18 and IL-2
showed profound effects on parasite expulsion, whereas neu-
tralization of IL-2 or IL-18 alone showed very modest ef-
fects. At present, we have no explanation that accounts for
this discrepancy. We considered the possibility that antibody
neutralization of IL-18 might be incomplete, and residual
IL-18 in combination with endogenous IL-2 might induce
mMCP-1. Alternatively, an unidentified factor might partly
replace the effect of IL-2 or IL-18. Thus, regulation of the
mMCP-1 response is complicated, and we need to study
further how STAT6 /  mice expel infected parasites.
We suspected that IL-18 might be produced by various
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parasite infection. In fact, IL-18 is stored in bronchial and in-
testinal epithelium (43, 44), and it is quite possible that S. ven-
ezuelensis locally stimulates epithelial cells to produce IL-18.
Helmby and Grencis (45) have reported that daily injec-
tion of 0.2  g of IL-18 into WT mice during infection with
Trichinella spiralis decreased the mastocytosis as well as IL-13
secretion from mesenteric lymph node stimulated with T. spi-
ralis antigen. Also, IL-18 /  mice infected with T. spiralis de-
veloped a high level of mastocytosis in the intestine during in-
fection, correlating with the rapid expulsion of the parasites.
These results suggest that IL-18 negatively regulates intestinal
mastocytosis and Th2 cytokine production. In sharp contrast,
our results presented here reveal that pretreatment of normal
mice with IL-18 and IL-2 induces significant recruitment and
activation of intestinal MMCs, resulting in extremely rapid
expulsion of adult S. venezuelensis worms. Our findings clearly
indicate that IL-18 positively regulates intestinal mastocytosis
in the presence of IL-2 and that treatment with IL-18 plus IL-2
has provided host mice with type 2 innate immunity that pro-
tects against gastrointestinal nematode infection.
There are several possibilities that account for these dis-
crepancies. Studies have contrasted the role of IL-4 in
STAT6 /  mice infected with either T. spiralis or Nippo-
strongylus brasiliensis. N. brasiliensis infection of STAT 6 /  mice
increase MMC and serum mMCP-1 levels, possibly through a
primary Th2 response (33, 34). In contrast, MMC numbers
and serum mMCP-1 responses were greatly decreased in
STAT 6 /  mice infected with T. spiralis, and a reduced Th2
response resulted in lower IgG1 production (46). Therefore,
type 2 cytokine responses are suppressed in STAT6 /  mice
infected with T. spiralis, even though these responses are nor-
mal in STAT6 /  mice inoculated with N. brasiliensis. In
other words, expulsion of T. spiralis is solely dependent on an
STAT6-mediated signal that is required to stimulate the con-
ditions that induce mast cells to degranulate optimally.
Helmby and Grencis reported that critical effects of IL-
18 in T. spiralis infection are independent of IFN-  and are
mediated by the direct down-regulatory effect of IL-18 on
IL-13 (45). It is important to point out that N. brasiliensis in-
oculation stimulates an almost pure type 2 cytokine re-
sponse, whereas T. spiralis induces production of consider-
able IFN-  in addition to IL-4. In this regard, adult T.
spiralis live within various cells and induce considerably more
IFN-  production, probably through the induction of IL-
12, than do N. brasiliensis, which live outside cells. Alterna-
tively, N. brasiliensis may inhibit IL-12 production by DCs
and macrophages. Therefore, it is possible that the work by
Helmby and Grencis depicts a down-regulatory role of IL-
18 on the Th2 response in the presence of IL-12 and its up-
regulatory role on the Th1 response in the early phase of T.
spiralis infections. In contrast to T. spiralis infection, S. vene-
zuelensis infection resembles N. brasiliensis infection in its ex-
tracellular location in the host. It is possible that IL-2 is pro-
duced in the early phase of S. venezuelensis infection, which,
along with endogenous IL-18, promotes MMC activation
and accumulation in the intestinal mucosa independently of
STAT6-mediated signal.
Here, we present a new paradigm of IL-18 activity in the
host mucosal immune response against gastrointestinal nem-
atode infections. IL-18, together with IL-12, plays an im-
portant role in the elimination of intracellular infections (3,
18), and, with IL-2, it can eradicate gastrointestinal nema-
tode infections by induction of functional intestinal MMCs.
Thus, IL-18 plays an important role in the host defense
against both intracellular and extracellular pathogens, and the
cytokine milieu of IL-18 determines its final effect on in-
fected parasites. At present, we have not yet identified the
cell source of IL-18 in mice inoculated with S. venezuelensis.
Our present results indicate that S. venezuelensis expulsion
might be induced by two types of intestinal MMC activa-
tion, IL-18–dependent (innate type 2) MMC activation and
Th2 cell–dependent (acquired type 2) MMC activation. We
also suggest a strong contribution of IL-3 and IL-9 in induc-
ing mMCP-1 production from MMCs.
MATERIALS AND METHODS
Mice and reagents. Specific pathogen-free male C57BL/6 mice and
Wistar rats were obtained from Charles River Breeding Laboratories.
Mast  cell-deficient WBB6F1-W/Wv mice (37) and littermate control
WBB6F1 /  mice were purchased from SLC Japan. C57BL/6 RAG-2 / 
mice were obtained from Taconic. Generation of C57BL/6 STAT6 / ,
IL-18 / , and IL-18R  /  mice has been detailed in our previous reports
(47–49). All mice were bred under specific pathogen-free conditions at the
animal facilities of Hyogo College of Medicine, Nishinomiya, Japan, and
were used at 8 to 12 wk of age. All animal experiments were conducted ac-
cording to the Guidelines for Animal Experiments at Hyogo College of
Medicine. Recombinant human IL-2 was provided by Ajinomoto Co., Inc.
Recombinant mouse IL-18 and IL-3/IL-9 were purchased from MBL In-
ternational Corporation and from Genzyme. Anti-mouse IL-9 mAb (clone,
D8402E8), biotinylated anti-mouse IL-9 mAb (clone, D9302C12), and
anti-mouse IL-2 mAb (clone, S4B6, rat IgG2a) were purchased from BD
Biosciences. Rabbit neutralizing anti-mouse-IL-18 IgG and control IgG an-
tibodies were partially purified using Protein-A sepharose column in our
laboratory. This anti–IL-18 antibody could completely neutralize 50 ng/ml
of IL-18 at the concentration of 10  g/ml in vitro. The administration of
200  g of anti-IL-18 antibody just before LPS challenge completely inhib-
ited LPS-induced liver injury in mice (11). Rat antibodies against mouse
IL-4 (11b11) and IL-4R  chain (M1) were purified in our laboratory. In-
traperitoneal administration of a mixture of 10 mg of anti-IL-4 and 10 mg
of IL-4R  antibodies 1 d before anti-IgD challenge completely inhibited
anti-IgD–induced IgE production in vivo (50).
Parasites. S. venezuelensis has been maintained in serial passage in male
Wister rats in our laboratory. S. venezuelensis L3 were obtained from fecal
culture by a filter paper method (36). Adult worms for intraduodenal im-
plantation were prepared as follows. Wister rats were inoculated with
30,000 infective larvae, and the upper half of the small intestines were re-
moved 7 to 10 d after infection. The intestine was then cut open longitudi-
nally and washed with PBS followed by incubation at 37 C for 80 min.
Worms that emerged from the intestine were washed with sterile PBS and
adjusted to an appropriate density. Adult worms suspended in 500  l of
PBS were injected into the duodenum of recipient mice (1,500 worms/
mouse) under anesthesia using a 1-ml syringe with a 22-gauge needle. Ani-
mals were inoculated s.c. with 5,000 S. venezuelensis L3 to initiate a com-
plete infection. The degree of infection of individual mice was monitored
by counting the number of eggs excreted daily (eggs/g feces).JEM VOL. 202, September 5, 2005 615
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In vivo treatment of mice. C57BL/6 normal, C57BL/6 STAT6 / ,
RAG-2 / , WBB6F1 / , or WBB6F1-W/Wv mice were injected i.p. daily
with PBS alone or with various combinations of IL-18 (0.5–2  g/d) and/or
IL-2 (2   103–1  104 U/d) for 13 d. To deplete CD4  T cells, C57BL/6
mice were injected i.p. with monoclonal antibody to CD4 (clone, GK1.5;
0.5 mg/d; ATCC: TIB-207) or control antibody (rat IgG2b; 0.5 mg/d; BD
Biosciences) 7 and 4 d before and 0, 3, and 7 d after IL-2 and/or IL-18 in-
jection. For some experiments, C57BL/6 mice were injected daily with IL-3
(0.013–0.1  g/d) and/or IL-9 (0.5  g/d) for 13 d. These mice were killed
on day 14 after cytokine treatments, and intestines, lungs, spleens, kidneys,
and livers were removed for histological examination.
Intraduodenal adult worm implantation. To measure the invasion of
adult S. venezuelensis into mouse intestinal mucosa, adult worms were im-
planted in the duodenum of recipient mice that had been treated with PBS
or IL-2 and/or IL-18 for 13 d, and the mouse intestines were removed 16 h
after implantation as described previously (36). Briefly, the intestine was cut
open longitudinally and washed lightly to remove fecal matter and worms
that were still in the lumen. Then the intestines were incubated at 37 C in
PBS for 3 h. The number of worms that emerged from the intestines was
counted. As we have reported previously, mucosal invasion of adult S. vene-
zuelensis in naive host mice was completed within 4 h, and these implanted
worms were rejected beyond 7 d after implantation in a mast cell–depen-
dent mechanism (36). Based on these results, we recovered invading worms
at 16 h after implantation.
ELISA. Mouse IL-9 was assayed by a specific sandwich ELISA with refer-
ence standard curves using known amounts of IL-9. To detect IL-9, we used
anti-IL-9 mAb (D8402E8) and biotinylated anti-mouse IL-9 mAb
(D9302C12; reference 22). The detection limit of this ELISA is 20 pg/ml.
ELISA kits for IL-3, IL-4, and IL-13 (R&D Systems), and IL-18 (MBL In-
ternational Corporation) were used. Levels of mMCP-1 in serum were mea-
sured with an mMCP-1 ELISA kit purchased from Moredun Scientific, Ltd.
Histological examination. For histological examination of MMC, tissue
samples (8–10 cm) were removed from the pyloric ring. The intestine was
opened longitudinally, flattened on a filter paper, and fixed in Carnoy’s fluid
and stained with Alcian blue, pH 0.3, and Safranin-O, as described previ-
ously (51). The number of mast cells in the epithelium and lamina propria
mucosa was counted in 10 villous crypt units (VCU) according to the
method described by Miller & Jarrett (52). Immunohistochemical staining
for mMCP-1 on 6- m-thick, paraffin wax–embedded, 10% formalin–fixed
sections was performed as follows. The dew-axed sections were treated with
0.3% H2O2 in methanol for 30 min, then incubated with 10% normal rabbit
serum in PBS for 1 h. The slides were incubated by sheep anti–mMCP-1
(Moredun Scientific, Ltd.) or normal sheep serum (Sigma-Aldrich) for 1 h,
followed by incubation with peroxidase-conjugated rabbit anti-sheep IgG
(Betty Laboratories, Inc.), and DAB reaction was performed.
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